Parameter Tenofovir Monotherapy (TM, Gr. 1, n=30) Peg-IFN plus Tenofovir Sequential Therapy (SQT, Gr. 2, n=28) P Values
Age (years) mean ± SD 35.4± 15 29.9 ± 11.9 P=0.13 (NS)
Sex (M:F) 22:08 24:04:00 P=0.24 ( NS)
Median Serum bilirubin (mg/dl; range) 0.7 (0.5-1.2) 0.75 (0.4-1.5) NS
Median Albumin (g/dl ; range) 4.3 (0.8-4.7) 4.35 (3.7-5) NS
Median ALT (IU/L; range) 60.5 (45-230) 62.5 (45-205) NS
HBV DNA (mean ± SD; log10 copies/ml) 6.26 ± 1.25 6.61± 1.16 P=0.33 (NS )
Table 1: Baseline Clinical and Virological Characteristics of patients